Drug Topics

MAY 12, 2025

Tirzepatide (Zepbound) demonstrated superiority compared to semaglutide (Wegovy) across the primary end point and 5 key secondary end points.

469

469

PharmaVoice

MAY 12, 2025

While AI-generated drugs grab headlines, the technology is making more of an impact doing less “glamorous” tasks.

162

162

STAT

MAY 13, 2025

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year international moratorium on the use of CRISPR and other DNA-editing tools to create genetically modified children, according to a draft of the declaration provided to STAT.  The move — coming more than seven years after Chinese researcher He Jiankui announced the birth of the world’s first CRISPR babies — is intended to send a clear signal to the global scientific co

144

144

Pharmacy Times

MAY 14, 2025

The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.

131

131

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MAY 14, 2025

Investigators also find that patients diagnosed with type 1 diabetes later in life do not have a better prognosis compared to those diagnosed earlier.

380

380

PharmaVoice

MAY 16, 2025

A stealth startup built by the partner of disgraced Theranos founder Elizabeth Holmes is taking a shot at a new blood test — an area where other companies are already making strides.

235

235

Pharmacy Times

MAY 14, 2025

The FDA approves belzutifan, the first oral treatment for pheochromocytoma and paraganglioma, offering a new treatment pathway for patients with these rare tumors.

FDA 127

FDA 127

Drug Topics

MAY 12, 2025

Douglas Hoey, CEO of NCPA, discusses what independent pharmacies can do to handle an influx of patients and what the chains situation means for the pharmacy landscape.

Independent Pharmacies 411

Independent Pharmacies 411

PharmaVoice

MAY 15, 2025

Amy Parison, who stepped into the lead financial role at the company in March, is managing Editas Medicine’s transition to a new gene editing platform while recovering from a major overhaul.

173

173

STAT

MAY 12, 2025

I’m taking Health and Human Services Secretary Robert F. Kennedy Jr. to court. I don’t want to do it. But I have to do it — not for myself, but to protect science.

135

135

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

MAY 13, 2025

Administration during peak vaccine effectiveness provides maximal protective benefit

Vaccines 126

Vaccines 126

Drug Topics

MAY 13, 2025

Pharmacist-led interventions improve medication adherence compared with the usual care for patients with heart failure and type 2 diabetes.

281

281

Pharmaceutical Technology

MAY 15, 2025

The FDA has approved MSDs Welireg for rare adrenal tumours, and AbbVies Emrelis for treating c-Met+ lung cancer patients.

FDA 110

FDA 110

STAT

MAY 14, 2025

WASHINGTON — In hours of combative congressional hearings Wednesday, health secretary Robert F. Kennedy Jr. swung between defending sweeping changes at his agency and backtracking on aspects of a reorganization he nevertheless said would be “painful.” He repeatedly cast doubts on reports about negative impacts of the changes, often calling them a “canard.

112

112

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MAY 14, 2025

Emrelis is a groundbreaking treatment for advanced non-small cell lung cancer, targeting high c-Met protein overexpression.

FDA 120

FDA 120

Drug Topics

MAY 12, 2025

Investigators find that unhealthy eating and inadequate or excessive sleeping duration could contribute to developing diabetic nephropathy.

315

315

PharmaVoice

MAY 12, 2025

But the therapies will need to prove their worth in the clinic over the next few years.

100

100

STAT

MAY 12, 2025

OpenAI on Monday released a large dataset for evaluating how well large language models answer questions related to health care. Experts lauded the open-source data and detailed evaluation rubrics, calling them “unprecedented” in scale and breadth. The project, HealthBench , marks OpenAI’s first foray into health care applications of AI, outside of external partnerships.

119

119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

MAY 13, 2025

The CMS Innovation Center rolled out its blueprint to reverse chronic disease and test more effective payment models Tuesday.

88

88

Drug Topics

MAY 15, 2025

Investigators report that patients experience weight loss with a reduced weekly dosage of the glucagon-like peptide-1 (GLP-1).

Dosage 315

Dosage 315

Pharmacy Times

MAY 12, 2025

A panelist discusses how physicians can collaborate with community pharmacists to enhance respiratory syncytial virus (RSV) vaccine uptake by leveraging pharmacists' expertise in patient education, addressing vaccine hesitancy through empathetic communication, and emphasizing the safety, benefits, and risks of RSV vaccination.

Vaccines 65

Vaccines Communication 65

STAT

MAY 15, 2025

I always knew Elizabeth Holmes would have a second act. But I’m shocked it’s starting while she’s still behind bars. Elizabeth is now serving an 11-year sentence for defrauding investors in Theranos and has been banned from participating in federal health programs. The company was built on her claim that, at 19 years old, she had invented a device capable of running hundreds of tests from just a single drop of blood.

143

143

Fierce Healthcare

MAY 12, 2025

House Republicans have unveiled their plans to cut federal spending and extend tax cuts, but experts warn that funding the cuts by slashing Medicaid and other entitlements will largely benefit families with higher incomes.

88

88

Drug Topics

MAY 15, 2025

NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.

315

315

pharmaphorum

MAY 14, 2025

Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025

78

78

STAT

MAY 12, 2025

The now 13-year-long legal saga over who invented CRISPR took yet another unexpected turn on Monday, in a ruling that could not only change U.S. ownership of patent rights to the groundbreaking gene-editing technology but more broadly redefine how the law determines when an invention has been made.  The U.S. Court of Appeals for the Federal Circuit sided with the University of California and the University of Vienna in their bid to revive a fight over foundational CRISPR-Cas9 patents that t

98

98

Fierce Healthcare

MAY 13, 2025

This is the beginning of a new era for HHS and American health more broadly, HHS Secretary Robert F. Kennedy Jr. wrote in a Tuesday notice. In this new era, patient choice and individual freedom will predominate over burdensome federal regulations.

92

92

Drug Topics

MAY 13, 2025

In the second part of our interview with Miranda Rochol, she discusses challenges regarding digital prescription solutions and the financial burdens these solutions are designed for pharmacists to overcome.

247

247

Pharmacy Times

MAY 12, 2025

PharmStart empowers pharmacy technicians to pursue their education with tuition-free prerequisites, addressing barriers to entering pharmacy school.

69

69

Pharmafile

MAY 12, 2025

Danish biopharma, Novo Nordisk, has announced that it will present new data on metabolic and cardiovascular health at the upcoming 32nd European Congress on Obesity (ECO). Central to the announcement will be findings related to semaglutide, a GLP-1 receptor agonist developed as a treatment for obesity and related cardiometabolic conditions. Semaglutide will be a key focus, […] The post Novo Nordisk unveils new semaglutide data on obesity and heart disease at ECO 2025 appeared first on Phar

77

77

Fierce Healthcare

MAY 12, 2025

The already massive nonprofit has grown substantially since the start of last year, though its operating performance and bottom line were both down.

68

68

Drug Topics

MAY 12, 2025

Larry King, PharmD, discusses how pharmacy interoperability is working to create collaborative care and get pharmacists in the game as he says.

247

247

Pharmacy Times

MAY 14, 2025

Like other high-risk groups, children with sickle cell disease have a heightened risk of invasive pneumococcal disease, even if they receive proper pneumococcal conjugate vaccine coverage.

Vaccines 73

Vaccines 73